"The U.S. Food and Drug Administration today notified Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug product"...
(Generic versions may still be available.)
Atromid-S Capsules (clofibrate capsules) is ethyl 2-(p-chlorophenoxy)-2-methyl-propionate, an antilipidemic agent.
Its molecular formula is C 12 H 15 O 3 Cl, molecular weight 242.7, and boiling point 148-150°C at 25 mm Hg. It is a stable, colorless to pale-yellow liquid with a faint odor and characteristic taste, soluble in common solvents but not in water. Each Atromid-S (clofibrate) Capsule contains 500 mg clofibrate for oral administration.
Atromid-S Capsules (clofibrate) contain the following inactive ingredients: D&C Red No. 28, D&C Red No. 30, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Red No. 28, FD&C Red No. 40, FD&C Yellow No. 6, gelatin.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Atromid-S Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.